Pathogenesis and risk factors for nontuberculous mycobacterial lung disease

Clinics in Chest Medicine

Volumn 36, Issue 1, 2015, Pages 1-11

  Honda, Jennifer R ^a,b,c   Knight, Vijaya ^b   Chan, Edward D ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Lung disease; Nontuberculous mycobacteria; Pathogenesis; Risk factors

Indexed keywords

GLYCOPEPTIDOLIPID; LIPID; LIPOGLYCAN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL VIRULENCE; BRONCHIECTASIS; CENTRILOBULAR NODULE; DISEASE PREDISPOSITION; DISSEMINATED NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE; ENVIRONMENTAL EXPOSURE; GENETIC DISORDER; HEREDITY; HOST CELL; HOST RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; IDIOPATHIC DISEASE; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; LUNG CAVITATION; LUNG INFECTION; LUNG NODULE; NONHUMAN; PATHOGENESIS; RISK FACTOR; VISCERAL NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE; VULNERABLE POPULATION; LUNG DISEASES; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PATHOGENICITY;

HUMANS; LUNG DISEASES; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; RISK FACTORS;

EID: 84922459972     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2014.10.001     Document Type: Review

References (70)

1. Kim Y.M., Kim M., Kim S.K., et al. Mycobacterial infections in coal workers' pneumoconiosis patients in South Korea. Scand J Infect Dis 2009, 41:656-662.
2. Rosenzweig D.Y. Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases. Chest 1979, 75:115-119.
3. Sonnenberg P., Murray J., Glynn J.R., et al. Risk factors for pulmonary disease due to culture-positive M. tuberculosis or non-tuberculous mycobacteria in South African gold miners. Eur Respir J 2000, 15:291-296.
4. Chan E.D., Kaminska A.M., Gill W., et al. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages. Scand J Infect Dis 2007, 39:690-696.
5. Noone P.G., Leigh M.W., Sannuti A., et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004, 169:459-467.
6. Tomii K., Iwata T., Oida K., et al. Aprobable case of adult Williams-Campbell syndrome incidentally detected by an episode of atypical mycobacterial infection. Nihon Kyobu Shikkan Gakkai Zasshi 1989, 27:518-522.
7. Uji M., Matsushita H., Watanabe T., et al. Acase of primary Sjögren's syndrome presenting with middle lobe syndrome complicated by nontuberculous mycobacteriosis. Nihon Kokyuki Gakkai Zasshi 2008, 46:55-59.
8. Witty L.A., Tapson V.F., Piantadosi C.A. Isolation of mycobacteria in patients with pulmonary alveolar proteinosis. Medicine 1994, 73:103-109.
9. Griffith D.E., Girard W.M., Wallace R.J. Clinical features of pulmonary disease caused by rapidly growing mycobacteria: an analysis of 154 patients. Am Rev Respir Dis 1993, 147:1271-1278.
10. Okumura M., Iwai K., Ogata H., et al. Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med 2008, 47:1465-1472.
11. Prince D.S., Peterson D.D., Steiner R.M., et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. NEngl J Med 1989, 321:863-868.
12. Chan E.D., Iseman M.D. Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease. Gend Med 2010, 7:5-18.
13. Iseman M.D., Buschman D.L., Ackerson L.M. Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1991, 144:914-916.
14. Kim R.D., Greenberg D.E., Ehrmantraut M.E., et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 2008, 178:1066-1074.
15. Tasaka S., Hasegawa N., Nishimura T., et al. Elevated serum adiponectin level in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Respiration 2010, 79:383-387.
16. Lord G.M., Matarese G., Howard J.K., et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998, 394:897-901.
17. Ordway D., Henao-Tamayo M., Smith E., et al. Animal model of Mycobacterium abscessus lung infection. JLeukoc Biol 2008, 83:1502-1511.
18. Kartalija M., Ovrutsky A.R., Bryan C.L., et al. Patients with non-tuberculous mycobacterial lung disease exhibit unique body and immune phenotypes. Am J Respir Crit Care Med 2012, 187:197-205.
19. Judge D.P., Dietz H.C. Marfan's syndrome. Lancet 2005, 366:1965-1976.
20. Champsi J., Young L.S., Bermudez L.E. Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection. Immunology 1995, 84:549-554.
21. Denis M., Ghadirian E. Transforming growth factor beta (TGF-b1) plays a detrimental role in the progression of experimental Mycobacterium avium infection; invivo and invitro evidence. Microb Pathog 1991, 11:367-372.
22. Paulson M.L., Olivier K.N., Holland S.M. Pulmonary non-tuberculous mycobacterial infection in congenital contractural arachnodactyly. Int J Tuberc Lung Dis 2012, 16:561-563.
23. Tsuyuguchi K., Suzuki K., Matsumoto H., et al. Effect of oestrogen on Mycobacterium avium complex pulmonary infection in mice. Clin Exp Immunol 2001, 123:428-434.
24. Colombo R.E., Hill S.C., Claypool R.J., et al. Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest 2010, 137:629-634.
25. Fowler C.J., Olivier K.N., Leung J.M., et al. Abnormal nasal nitric oxide production, ciliary beat frequency, and Toll-like receptor response in pulmonary nontuberculous mycobacterial disease epithelium. Am J Respir Crit Care Med 2013, 187:1374-1381.
26. Fujita J., Ohtsuki Y., Suemitsu I., et al. Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease. Eur Respir J 1999, 13:535-540.
27. Kim T.S., Koh W.J., Han J., et al. Hypothesis on the evolution of cavitary lesions in nontuberculous mycobacterial pulmonary infection: thin-section CT and histopathologic correlation. AJR Am J Roentgenol 2005, 184:1247-1252.
28. Moore E.H. Atypical mycobacterial infection in the lung: CT appearance. Radiology 1993, 187:777-782.
29. Chan ED, Iseman MD. Bronchiectasis. In: Broaddus EJ, King TE, Lazarus SC, etal, editors. Textbook of respiratory medicine. 6th edition. Elsevier Press; in press.
30. Malcolm K.C., Nichols E.M., Caceres S.M., et al. Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival. PLoS One 2013, 8:e57402.
31. McGarvey J., Bermudez L.E. Pathogenesis of nontuberculous mycobacteria infections. Clin Chest Med 2002, 23:569-583.
32. Rose S.J., Bermudez L.E. Mycobacterium avium biofilm attenuates mononuclear phagocyte function by triggering hyperstimulation and apoptosis during early infection. Infect Immun 2014, 82:405-412.
33. Puzo G. The carbohydrate- and lipid-containing cell wall of mycobacteria, phenolic glycolipids: structure and immunological properties. Crit Rev Microbiol 1990, 17:305-327.
34. Pourshafie M.R., Sonnenfeld G., Barrow W.W. Immunological and ultrastructural disruptions of T lymphocytes following exposure to the glycopeptidolipid isolated from the Mycobacterium avium complex. Scand J Immunol 1999, 49:405-410.
35. Barrow W.W., de Sousa J.P., Davis T.L., et al. Immunomodulation of human peripheral blood mononuclear cell functions by defined lipid fractions of Mycobacterium avium. Infect Immun 1993, 61:5286-5293.
36. Enomoto K., Oka S., Fujiwara N., et al. Rapid serodiagnosis of Mycobacterium avium-intracellulare complex infection by ELISA with cord factor (trehalose 6, 6'-dimycolate), and serotyping using the glycopeptidolipid antigen. Microbiol Immunol 1998, 42:689-696.
37. Chatterjee D., Khoo K.H. The surface glycopeptidolipids of mycobacteria: structures and biological properties. Cell Mol Life Sci 2001, 58:2018-2042.
38. Freeman R., Geier H., Weigel K.M., et al. Roles for cell wall glycopeptidolipid in surface adherence and planktonic dispersal of Mycobacterium avium. Appl Environ Microbiol 2006, 72:7554-7558.
39. Howard S.T., Rhoades E., Recht J., et al. Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. Microbiology 2006, 152:1581-1590.
40. Byrd T.F., Lyons C.R. Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection. Infect Immun 1999, 67:4700-4707.
41. Rhoades E.R., Archambault A.S., Greendyke R., et al. Mycobacterium abscessus glycopeptidolipids mask underlying cell wall phosphatidyl-myo-inositol mannosides blocking induction of human macrophage TNF-alpha by preventing interaction with TLR2. JImmunol 2009, 183:1997-2007.
42. Catherinot E., Roux A.L., Macheras E., et al. Acute respiratory failure involving an R variant of Mycobacterium abscessus. JClin Microbiol 2009, 47:271-274.
43. Sanguinetti M., Ardito F., Fiscarelli E., et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. JClin Microbiol 2001, 39:816-819.
44. Pawlik A., Garnier G., Orgeur M., et al. Identification and characterization of the genetic changes responsible for the characteristic smooth-to-rough morphotype alterations of clinically persistent Mycobacterium abscessus. Mol Microbiol 2013, 90:612-629.
45. Pang L., Tian X., Pan W., et al. Structure and function of mycobacterium glycopeptidolipids from comparative genomics perspective. JCell Biochem 2013, 114:1705-1713.
46. Sweet L., Schorey J.S. Glycopeptidolipids from Mycobacterium avium promote macrophage activation in a TLR2- and MyD88-dependent manner. JLeukoc Biol 2006, 80:415-423.
47. Barrow W.W., Davis T.L., Wright E.L., et al. Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8. Infect Immun 1995, 63:126-133.
48. Takegaki Y. Effect of serotype specific glycopeptidolipid (GPL) isolated from Mycobacterium avium complex (MAC) on phagocytosis and phagosome-lysosome fusion of human peripheral blood monocytes. Kekkaku 2000, 75:9-18.
49. Bhatnagar S., Schorey J.S. Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory. JBiol Chem 2007, 282:25779-25789.
50. Tereletsky M.J., Barrow W.W. Postphagocytic detection of glycopeptidolipids associated with the superficial L1 layer of Mycobacterium intracellulare. Infect Immun 1983, 41:1312-1321.
51. Cebula B.R., Rocco J.M., Maslow J.N., et al. Mycobacterium avium serovars 2 and 8 infections elicit unique activation of the host macrophage immune responses. Eur J Clin Microbiol Infect Dis 2012, 31:3407-3412.
52. Chatterjee D., Khoo K.H. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 1998, 8:113-120.
53. Maeda N., Nigou J., Herrmann J.L., et al. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. JBiol Chem 2003, 278:5513-5516.
54. Vignal C., Guerardel Y., Kremer L., et al. Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism. JImmunol 2003, 171:2014-2023.
55. Wieland C.W., Knapp S., Florquin S., et al. Non-mannose-capped lipoarabinomannan induces lung inflammation via toll-like receptor 2. Am J Respir Crit Care Med 2004, 170:1367-1374.
56. Winthrop K.L., Baxter R., Liu L., et al. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis 2013, 72:37-42.
57. Doucette K., Fishman J.A. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 2004, 38:1428-1439.
58. French A.L., Benator D.A., Gordin F.M. Nontuberculous mycobacterial infections. Med Clin North Am 1997, 81:361-379.
59. Dorman S.E., Picard C., Lammas D., et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004, 364:2113-2121.
60. Döffinger R., Jouanguy E., Dupuis S., et al. Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. JInfect Dis 2000, 181:379-384.
61. Dupuis S., Dargemont C., Fieschi C., et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001, 293:300-303.
62. Prando C., Samarina A., Bustamante J., et al. Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore) 2013, 92:109-122.
63. Haverkamp M.H., van de Vosse E., van Dissel J.T. Nontuberculous mycobacterial infections in children with inborn errors of the immune system. JInfect 2014, 68:S134-S150.
64. Minegishi Y., Saito M., Morio T., et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006, 25:745-755.
65. Filipe-Santos O., Bustamante J., Haverkamp M.H., et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. JExp Med 2006, 203:1745-1759.
66. Chi C.Y., Chu C.C., Liu J.P., et al. Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1 16:02 and HLA-DQB1 05:02 and the reactivation of latent varicella-zoster virus infection. Blood 2013, 121:1357-1366.
67. Hsu A.P., Johnson K.D., Falcone E.L., et al. GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood 2013, 121:3830-3837.
68. Bustamante J., Arias A.A., Vogt G., et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol 2011, 12:213-221.
69. Bogunovic D., Byun M., Durfee L.A., et al. Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency. Science 2012, 337:1684-1688.
70. Hambleton S., Salem S., Bustamante J., et al. IRF8 mutations and human dendritic-cell immunodeficiency. NEngl J Med 2011, 365:127-138.